134 related articles for article (PubMed ID: 23306929)
1. [A case report of successful treatment for rectosigmoid cancer with peritoneal dissemination after neoadjuvant chemoradiotherapy with XELOX and bevacizumab].
Ishida M; Miyazawa T; Ebe K; Koide N; Fujita N; Honma K; Ikarashi T
Gan To Kagaku Ryoho; 2013 Jan; 40(1):103-5. PubMed ID: 23306929
[TBL] [Abstract][Full Text] [Related]
2. [A case report of pathologically complete response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy with XELOX and bevacizumab].
Miyazawa T; Ebe K; Fujita N; Koide N; Honma K; Ikarashi T
Gan To Kagaku Ryoho; 2012 Jun; 39(6):1001-3. PubMed ID: 22705702
[TBL] [Abstract][Full Text] [Related]
3. [A case wherein bevacizumab/XELOX combination therapy was remarkably effective for the treatment of extensive dissemination in advanced colon cancer, and the primary lesion could be resected].
Kubo H; Nakasuga C; Tada K; Miyahara M; Hasegawa H
Gan To Kagaku Ryoho; 2013 Nov; 40(11):1545-8. PubMed ID: 24231712
[TBL] [Abstract][Full Text] [Related]
4. [Neoadjuvant chemoradiotherapy with capecitabine and oxaliplatin for the treatment of locally advanced lower rectal cancer].
Murata K; Okamura S; Okubo H; Owada Y; Nishigaki T; Wada Y; Kato R; Makino S; Takeoka T; Okada K; Fukuchi N; Ebisui C; Kinuta M
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2020-2. PubMed ID: 24393999
[TBL] [Abstract][Full Text] [Related]
5. [Recurrent liver sigmoid cancer responding remarkably to neoadjuvant chemotherapy using bevacizumab/XELOX: report of a case].
Uehara M; Sakamoto K; Konishi S; Hamasu S; Nishitai R; Manaka D
Gan To Kagaku Ryoho; 2011 Sep; 38(9):1541-3. PubMed ID: 21918359
[TBL] [Abstract][Full Text] [Related]
6. [A case of advanced rectal cancer that showed complete response to the addition of XELOX+bevacizumab therapy to preoperative chemoradiotherapy with S-1/CPT-11].
Takahashi T; Namiki K; Matsumoto H; Konno F; Mitsui K; Yoshida R
Gan To Kagaku Ryoho; 2014 May; 41(5):653-5. PubMed ID: 24917016
[TBL] [Abstract][Full Text] [Related]
7. [A case of necrotizing fasciitis developed in a patient with recurrent rectal cancer treated with chemotherapy].
Shimada A; Nakamura T; Ishii M; Chiba N; Ishikawa S; Arisawa Y; Hashimoto M
Gan To Kagaku Ryoho; 2013 May; 40(5):663-5. PubMed ID: 23863596
[TBL] [Abstract][Full Text] [Related]
8. A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer.
Zhao L; Bai C; Shao Y; Guan M; Jia N; Xiao Y; Qiu H; Zhang F; Yang T; Zhong G; Chen S
Cancer Lett; 2011 Nov; 310(2):134-9. PubMed ID: 21782322
[TBL] [Abstract][Full Text] [Related]
9. [A case in which chemotherapy-resistant sigmoid colon cancer was controlled effectively by radiotherapy and resection].
Sato N; Mukubo H; Nakanuma S; Yasui T; Kita I; Takanaka T
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1996-8. PubMed ID: 24393991
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of neoadjuvant chemotherapy with XELOX plus bevacizumab for locally advanced rectal cancer.
Uehara K; Ishiguro S; Sakamoto E; Maeda A; Inoue M; Tojima Y; Kobayashi S; Omiya N; Ishizuka N; Nakao A; Goto H; Nagino M
Jpn J Clin Oncol; 2011 Aug; 41(8):1041-4. PubMed ID: 21803876
[TBL] [Abstract][Full Text] [Related]
11. [A case of sigmoid colon cancer with a sigmoidovesical fistula treated with preoperative XELOX+bevacizumab therapy and urinary bladder-conserving surgery].
Miura T; Aoki K; Suto A; Yoshikawa T; Ikenaga SK; Kawashima H; Shibasaki I; Endo M
Gan To Kagaku Ryoho; 2014 Mar; 41(3):387-90. PubMed ID: 24743290
[TBL] [Abstract][Full Text] [Related]
12. [A case of pathological complete response with neoadjuvant XELOX chemotherapy for locally advanced rectal cancer].
Kitahara T; Takemasa I; Inoue A; Osawa H; Miyo M; Mokutani Y; Ogawa H; Naito A; Hamabe A; Hiraki M; Munakata K; Uemura M; Nishimura J; Hata T; Mizushima T; Yamamoto H; Doki Y; Mori M
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1569-71. PubMed ID: 25731255
[TBL] [Abstract][Full Text] [Related]
13. [Our experiences of XELOX + bevacizumab for two cases of metastatic sigmoid colon cancer].
Shioiri M; Kojima K; Yamamoto S; Watanabe Y; Mizutani M; Kamimura K
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2511-3. PubMed ID: 21224623
[TBL] [Abstract][Full Text] [Related]
14. [A case of locally advanced rectal cancer successfully treated by laparoscopic intersphincteric resection and effective neoadjuvant chemoradiation therapy].
Kanamoto A; Nakano T; Ojima E; Sasaki S
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1974-7. PubMed ID: 24393984
[TBL] [Abstract][Full Text] [Related]
15. [Our experience of the treatment with XELOX±Bevacizumab for unresectable advanced colorectal cancer].
Kashiwagi S; Maeda K; Fuyuhiro Y; Nagahara H; Kimura K; Amano R; Noda E; Kubo N; Tanaka H; Muguruma K; Yashiro M; Yamada N; Nakata B; Ohira M; Ishikawa T; Hirakawa K
Gan To Kagaku Ryoho; 2011 Nov; 38(12):1936-8. PubMed ID: 22202244
[TBL] [Abstract][Full Text] [Related]
16. [A case of locally advanced colorectal cancer with abscess responding to 5-fluorouracil, leucovorin, and oxaliplatin plus bevacizumab].
Kuwabara H; Watanabe S; Liu B; Mitsuoka A; Sanada T; Nakajima K; Goseki N
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2032-4. PubMed ID: 24394003
[TBL] [Abstract][Full Text] [Related]
17. Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.
Shanmugan S; Arrangoiz R; Nitzkorski JR; Yu JQ; Li T; Cooper H; Konski A; Farma JM; Sigurdson ER
Ann Surg Oncol; 2012 Jul; 19(7):2178-85. PubMed ID: 22395978
[TBL] [Abstract][Full Text] [Related]
18. [Two cases of locally advanced colorectal cancer curatively resected after neoadjuvant chemotherapy with 5-fluorouracil, leucovorin, and oxaliplatin plus panitumumab].
Nakayasu Y; Yoshimatsu K; Yokomizo H; Osawa G; Yano Y; Nakayama M; Sakuma A; Yamaguchi K; Shiozawa S; Shimakawa T; Katsube T; Naritaka Y
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2029-31. PubMed ID: 24394002
[TBL] [Abstract][Full Text] [Related]
19. [A case of juvenile colon cancer with peritoneal dissemination treated effectively by use of resection and chemotherapy].
Yonemitsu K; Kawamoto S; Maeno H; Okubo S; Hosaka S; Umemoto S; Yoshida T; Ohara C
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1695-7. PubMed ID: 25731299
[TBL] [Abstract][Full Text] [Related]
20. T3+ and T4 rectal cancer patients seem to benefit from the addition of oxaliplatin to the neoadjuvant chemoradiation regimen.
Martijnse IS; Dudink RL; Kusters M; Vermeer TA; West NP; Nieuwenhuijzen GA; van Lijnschoten I; Martijn H; Creemers GJ; Lemmens VE; van de Velde CJ; Sebag-Montefiore D; Glynne-Jones R; Quirke P; Rutten HJ
Ann Surg Oncol; 2012 Feb; 19(2):392-401. PubMed ID: 21792506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
